💊 #TNBC in 2026: New hope through #TROP2 -directed ADCs, including Datroway(datopotamab deruxtecan) and Trodelvy(sacituzumab govitecan), alongside immunotherapy and biomarker-driven strategies.
🚀What new vulnerabilities can we target? MCE supports breast cancer research toward the next breakthrough.